Ishwarlal Jialal Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2022	A comparison of the ratios of C-reactive protein and triglycerides to high-density lipoprotein-cholesterol as biomarkers of metabolic syndrome in African Americans and non-Hispanic Whites.
11/2021	The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome.
4/2021	Chemerin levels in metabolic syndrome: a promising biomarker.
1/2021	Comparison of the triglyceride-waist circumference and the C-reactive protein-waist circumference indices in nascent metabolic syndrome.
1/2021	The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome.
1/2021	Increased inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome.
1/2021	Metabolites that activate the inflammasome in nascent metabolic syndrome.
11/2020	Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome.
7/2020	Decreased homoserine levels in metabolic syndrome.
3/2020	Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ishwarlal Jialal Research Topics

Disease

70	Inflammation (Inflammations) 01/2021 - 09/2002
51	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2003
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
30	Atherosclerosis 01/2016 - 01/2002
29	Insulin Resistance 03/2022 - 03/2003
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2006
11	Thrombosis (Thrombus) 12/2011 - 03/2002
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2002
8	Hyperglycemia 05/2016 - 01/2005
7	Body Weight (Weight, Body) 01/2022 - 01/2005
7	Obesity 01/2021 - 07/2008
7	Dyslipidemias (Dyslipidemia) 01/2021 - 03/2002
6	Hypertriglyceridemia 01/2021 - 03/2002
4	Hypertension (High Blood Pressure) 01/2019 - 02/2011
4	Weight Loss (Weight Reduction) 11/2014 - 01/2005
3	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2014
3	Fibrosis (Cirrhosis) 01/2021 - 11/2014
3	Neoplasms (Cancer) 12/2018 - 10/2011
3	Hypercholesterolemia 12/2016 - 09/2006
3	Diabetic Angiopathies (Diabetic Angiopathy) 01/2016 - 07/2015
3	Hyperlipidemias (Hyperlipidemia) 02/2014 - 02/2002
3	Atherosclerotic Plaque (Atheroma) 02/2009 - 03/2004
2	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 01/2022
2	Insulinoma 01/2022 - 11/2014
2	Pancreatitis 05/2019 - 08/2010
2	Chronic Renal Insufficiency 01/2017 - 03/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 03/2002
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016 - 01/2014
2	Wounds and Injuries (Trauma) 09/2013 - 11/2010
2	Acute Coronary Syndrome 06/2013 - 02/2009
2	Hemolysis 03/2012 - 03/2002

Drug/Important Bio-Agent (IBA)

52	C-Reactive ProteinIBA 01/2022 - 02/2002
46	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2002
19	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2016 - 02/2008
13	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2005
13	CytokinesIBA 09/2019 - 12/2002
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 03/2002
12	oxidized low density lipoproteinIBA 01/2022 - 03/2002
10	Insulin (Novolin)FDA Link 03/2022 - 03/2003
10	HDL CholesterolIBA 01/2022 - 03/2002
10	AdiponectinIBA 11/2021 - 11/2007
10	AdipokinesIBA 01/2021 - 01/2013
10	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2002
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2002
9	LDL CholesterolIBA 01/2022 - 01/2007
9	alpha-Tocopherol FDA Link 03/2008 - 01/2002
9	AntioxidantsIBA 05/2006 - 01/2002
7	LeptinIBA 11/2021 - 11/2011
7	LipidsIBA 03/2020 - 02/2004
7	LDL Lipoproteins (beta Lipoproteins)IBA 05/2019 - 03/2002
7	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2003
6	InterleukinsIBA 01/2019 - 01/2005
6	Superoxides (Superoxide)IBA 10/2012 - 03/2006
6	Plasminogen Activators (Plasminogen Activator)IBA 10/2005 - 03/2002
5	Messenger RNA (mRNA)IBA 03/2019 - 01/2005
5	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2017 - 08/2006
5	Pattern Recognition ReceptorsIBA 11/2014 - 02/2011
5	Human Serum Albumin FDA LinkGeneric 11/2013 - 03/2009
5	Simvastatin (Zocor)FDA LinkGeneric 06/2008 - 02/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 12/2002
4	NF-kappa B (NF-kB)IBA 01/2010 - 01/2005
3	AutoantibodiesIBA 03/2022 - 03/2002
3	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2021 - 11/2017
3	InflammasomesIBA 01/2021 - 01/2017
3	HDL LipoproteinsIBA 01/2021 - 08/2010
3	p38 Mitogen-Activated Protein KinasesIBA 01/2019 - 01/2016
3	Streptozocin (Streptozotocin)FDA Link 01/2017 - 09/2011
3	Cell Adhesion MoleculesIBA 04/2016 - 12/2004
3	Nonesterified Fatty Acids (NEFA)IBA 12/2014 - 04/2010
3	Vitamin A (Retinol)FDA LinkGeneric 12/2014 - 11/2011
3	Toll-Like Receptor 4IBA 11/2014 - 02/2011
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014 - 03/2006
3	3-nitrotyrosineIBA 10/2012 - 03/2006
3	Plasminogen Activator Inhibitor 1IBA 10/2011 - 01/2003
3	P-SelectinIBA 06/2008 - 03/2002
2	Insulin ReceptorIBA 03/2022 - 01/2022
2	CreatinineIBA 01/2022 - 05/2007
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2017
2	Apolipoproteins B (ApoB)IBA 01/2021 - 12/2016
2	EndotoxinsIBA 07/2020 - 11/2014
2	alpha-2-HS-GlycoproteinIBA 07/2020 - 07/2015
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 08/2008
2	ChemokinesIBA 09/2019 - 12/2004
2	Lipoproteins (Lipoprotein)IBA 05/2019 - 03/2002
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 02/2013
2	CollagenIBA 01/2019 - 11/2014
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 11/2011
2	ResistinIBA 11/2016 - 03/2013
2	Folic Acid (Vitamin M)FDA LinkGeneric 08/2016 - 03/2003
2	Small Interfering RNA (siRNA)IBA 05/2016 - 01/2014
2	Peptides (Polypeptides)IBA 05/2016 - 01/2014
2	Interleukin-8 (Interleukin 8)IBA 04/2016 - 03/2004
2	Retinaldehyde (Retinal)IBA 01/2016 - 01/2014
2	lipopolysaccharide-binding proteinIBA 07/2015 - 11/2014
2	NPHS2 proteinIBA 11/2014 - 08/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2014 - 11/2006
2	BilirubinIBA 03/2012 - 03/2002
2	Toll-Like Receptor 2IBA 02/2011 - 01/2010

Therapy/Procedure

22	Therapeutics 01/2022 - 03/2002
4	Drug Therapy (Chemotherapy) 01/2019 - 11/2007